These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15922148)

  • 1. Newer therapeutic approaches for systemic lupus erythematosus.
    Ginzler EM; Dvorkina O
    Rheum Dis Clin North Am; 2005 May; 31(2):315-28. PubMed ID: 15922148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents.
    Dooley MA; Ginzler EM
    Rheum Dis Clin North Am; 2006 Feb; 32(1):91-102, ix. PubMed ID: 16504823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus: modern strategies for management: a moving target.
    King JK; Hahn BH
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):971-87. PubMed ID: 18068856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticytokine therapy in systemic lupus erythematosus.
    Yoo DH
    Lupus; 2010 Oct; 19(12):1460-7. PubMed ID: 20947558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus in children: current and emerging therapies.
    Macdermott EJ; Adams A; Lehman TJ
    Lupus; 2007; 16(8):677-83. PubMed ID: 17711907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble mediators as therapeutic targets in systemic lupus erythematosus: cytokines, immunoglobulin receptors, and the complement system.
    Kirou KA; Salmon JE; Crow MK
    Rheum Dis Clin North Am; 2006 Feb; 32(1):103-19, ix. PubMed ID: 16504824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies.
    Sousa E; Isenberg D
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):563-74. PubMed ID: 19591785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus--2005 annus mirabilis?
    Isenberg D; Rahman A
    Nat Clin Pract Rheumatol; 2006 Mar; 2(3):145-52. PubMed ID: 16932674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell-directed therapies in systemic lupus erythematosus.
    Tieng AT; Peeva E
    Semin Arthritis Rheum; 2008 Dec; 38(3):218-27. PubMed ID: 18206214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on emerging drug therapies for systemic lupus erythematosus.
    Mok CC
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):53-70. PubMed ID: 20148712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatments for SLE: cell-depleting and anti-cytokine therapies.
    Anolik JH; Aringer M
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):859-78. PubMed ID: 16150407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluation of biologic therapies in systemic lupus erythematosus.
    Bruce IN
    Curr Opin Rheumatol; 2010 May; 22(3):273-7. PubMed ID: 20177385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of systemic lupus erythematosus.
    O'Neill SG; Schrieber L
    Autoimmun Rev; 2005 Jul; 4(6):395-402. PubMed ID: 16081031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trials and tribulations in systemic lupus erythematosus.
    Wofsky D
    Bull NYU Hosp Jt Dis; 2010; 68(3):175-8. PubMed ID: 20969548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of dehydroepiandrosterone (DHEA) as a therapeutic agent in systemic lupus erythematosus.
    Van Vollenhoven RF; McGuire JL
    Ann Med Interne (Paris); 1996; 147(4):290-6. PubMed ID: 8952750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F; Isenberg DA
    Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cells in SLE: different biological drugs for different pathogenic mechanisms.
    Diamanti AP; Rosado MM; Carsetti R; Valesini G
    Autoimmun Rev; 2007 Dec; 7(2):143-8. PubMed ID: 18035325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell depletion therapy for 19 patients with refractory systemic lupus erythematosus.
    Podolskaya A; Stadermann M; Pilkington C; Marks SD; Tullus K
    Arch Dis Child; 2008 May; 93(5):401-6. PubMed ID: 18039744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.